Discover the detailed record of transactions filed by Sblendorio Glenn, 董事. Insider active across 5 companies, notably Intercept Pharmaceuticals, INC.. Cumulatively, 32 reports have been logged. Split: 0 buy · 3 sells. Total volume traded: €2m. Activity tracked since 27 May 2021. The latest transaction was disclosed on 27 April 2026 (Disposition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Sblendorio Glenn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
SBLENDORIO GLENN is Chief Executive Officer and Director. He has 32 filings in total, and in the sampled recent filings the reported volume is 0 in buys and 3782427 in sells, with transactions ranging from 2016-01-04 to 2026-04-27.